<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Med | wechat-feeds</title><link>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</link><description>Best Evidence, Best Benefit</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 05 Mar 2021 12:01:43 +0800</pubDate><image><url>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Med | wechat-feeds</title><link>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>主要病理学缓解近50%！首个O+Y新辅助治疗NSCLC的II期试验发表，“去化疗时代”更近一步？</title><link>https://mp.weixin.qq.com/s/P5HgqPjZa_EJiljVi4bc4A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lXeemrd2701IicwTPrCsEuI8ZqBhvicfYCzrfvlL5qYouRgAUBfCMpZFJibqRL9UZonBdbbdoicYdg6sQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>近50%的患者手术病理残留显著减少]]></content:encoded><pubDate>Fri, 05 Mar 2021 11:53:17 +0800</pubDate></item><item><title>2021肿瘤新药数据卡——伏美替尼</title><link>https://mp.weixin.qq.com/s/BQS7OYbAYa7Nhlq70DMoNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lXeemrd2701IicwTPrCsEuI8F2wpDUUK0uJbbIgbhop0Xg0TlRR613OwicEiapZhfNHXjzFWtQ05xeKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Thu, 04 Mar 2021 12:20:29 +0800</pubDate></item><item><title>2021年2月 | 失败临床研究TOP5</title><link>https://mp.weixin.qq.com/s/igcTNUO0JI3MI6U-AKjYiw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lVrXDe3BEI1zqamVA7IK1DovWUDgxZgNia8KdVLQK5ps1a7riaGJ4f2TyknqCP5mUaIcYlyvUYwRvnw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Wed, 03 Mar 2021 09:42:16 +0800</pubDate></item><item><title>晚期胃癌一线联合：化疗爱CLDN18.2，不爱MMP9？</title><link>https://mp.weixin.qq.com/s/hsPn0isOpLfXUUQDk0c4wA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lVsJO97jBew0Za3g8Aa57cM2CHNQ0xTa3o90RTmblAZT34DaoGAvOQ9qrL4vSVQ0IZ639pTwyVE0Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Andecaliximab和Zolbetuximab的“心酸”对照]]></content:encoded><pubDate>Mon, 01 Mar 2021 09:55:20 +0800</pubDate></item><item><title>铁打的中心，流水的PI？</title><link>https://mp.weixin.qq.com/s/TuRgBK9PhWetVdkV1lcCdQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lWujDP2nkgKia94hxgvEfc8nMMGz9eYcibaywqLGkwbYNSEOOpIO6jjYiar8xcwGOdz2TW11j62E7PxQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有关医疗学术中心的“大实话”，你认同几条？]]></content:encoded><pubDate>Sat, 27 Feb 2021 10:16:01 +0800</pubDate></item><item><title>正月十五，赏医学美图！</title><link>https://mp.weixin.qq.com/s/T_aXG4odVwKMe-Na1cFRnQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lWujDP2nkgKia94hxgvEfc8nWTgJyc2Cic5ibgKF0O6xA0zIw1btZKrAGEXO4iapyFAXtMzBYIo1KE2Yg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>肿瘤顶级期刊封面大赏]]></content:encoded><pubDate>Fri, 26 Feb 2021 09:38:07 +0800</pubDate></item><item><title>2020肿瘤新药数据卡——伊尼妥单抗</title><link>https://mp.weixin.qq.com/s/HwF2om7XqX5WPT0T4gK9Cw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lWYyYQgtAv7doxvzCgnfld8c45KQJRGLb7K2v8vL0v6eA4BSRFTKxGCibM0LLpVjRUI8spVpfUceicA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Thu, 25 Feb 2021 10:17:49 +0800</pubDate></item><item><title>循证慢头条：HER2阳性乳腺癌新增后线选择，前列腺癌首个口服激素疗法</title><link>https://mp.weixin.qq.com/s/F8kJ5uTa4f5mCnMD8ZpkNQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lWujDP2nkgKia94hxgvEfc8nO0qHSWwSkxW372gZSwDLS9fkuVDxSp65giaySFIYrzzf8fnpibhQQcDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药魔方]]></content:encoded><pubDate>Wed, 24 Feb 2021 12:03:30 +0800</pubDate></item><item><title>首个PD-L1+MEK联合疗法用于三阴乳腺癌失败：多情却被无情扰？</title><link>https://mp.weixin.qq.com/s/RWdQSIQeUsNPtBU2pVwaBQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lXJJYkceF35Z1zX4lQv5NlqBUgGg9ia3GMNfVia0LqxZpiabYKEuM3bVNQLvc5jnQHXOwuINyBfLFR2g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>落花有意，流水无情]]></content:encoded><pubDate>Mon, 22 Feb 2021 11:21:46 +0800</pubDate></item><item><title>分享图片</title><link>https://mp.weixin.qq.com/s/rJcGDrXyZ8PKghzASdwRNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/icQmTvWzib7lVgDJRfCYG2qEMOvetzxfKULs2ibEGXX9CfKGmgT0b40lhmqLp0ibPXm6ulvHSukRPbeKI47F8s9dVw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 18 Feb 2021 12:16:46 +0800</pubDate></item></channel></rss>